237 related articles for article (PubMed ID: 2551491)
1. Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40.
Larsson O; Barrios C; Latham C; Ruiz J; Zetterberg A; Zickert P; Wejde J
Cancer Res; 1989 Oct; 49(20):5605-10. PubMed ID: 2551491
[TBL] [Abstract][Full Text] [Related]
2. Effect of virus-transformation and growth factor stimulation on isoprene biosynthesis in human fibroblasts: a correlation to cell growth.
Larsson O
Cancer Biochem Biophys; 1995 Jan; 14(4):243-56. PubMed ID: 7767898
[TBL] [Abstract][Full Text] [Related]
3. Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells.
Larsson O; Johansson BM
Cancer Res; 1987 Sep; 47(18):4825-9. PubMed ID: 3040232
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
Maltese WA; Sheridan KM
J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
[TBL] [Abstract][Full Text] [Related]
5. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
Wejde J; Blegen H; Larsson O
Anticancer Res; 1992; 12(2):317-24. PubMed ID: 1580550
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control.
Peffley DM
Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367
[TBL] [Abstract][Full Text] [Related]
7. The effect of factors released from the tumor-transformed cells on DNA synthesis, mitosis, and cellular enlargement in 3T3 fibroblasts.
Dafgård E; Engström W; Larsson O; Zetterberg A
J Cell Physiol; 1987 Aug; 132(2):295-302. PubMed ID: 3040778
[TBL] [Abstract][Full Text] [Related]
8. The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate.
Gayen AK; Peffley DM
Arch Biochem Biophys; 1995 Oct; 322(2):475-85. PubMed ID: 7574724
[TBL] [Abstract][Full Text] [Related]
9. Requirement for mevalonate in cycling cells: quantitative and temporal aspects.
Doyle JW; Kandutsch AA
J Cell Physiol; 1988 Oct; 137(1):133-40. PubMed ID: 3170653
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to increased expression of IGF-1 receptors in human fibroblasts.
Carlberg M; Larsson O
Exp Cell Res; 1996 Feb; 223(1):142-8. PubMed ID: 8635486
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
Straka MS; Panini SR
Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
[TBL] [Abstract][Full Text] [Related]
13. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of mevalonate in the growth of normal and neoplastic human mammary epithelial cells.
Larsson O; Blegen H
Anticancer Res; 1993; 13(4):1075-9. PubMed ID: 8352528
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
17. Role of biosynthesis of cholesterol and isoprenoid derivatives in regulation of G1 progression and cell proliferation of 3T6 cells.
Larsson O
J Cell Physiol; 1987 Oct; 133(1):163-8. PubMed ID: 3667703
[TBL] [Abstract][Full Text] [Related]
18. Effects of mevinolin and mevalonate on cell growth in several transformed cell lines.
Fairbanks KP; Barbu VD; Witte LD; Weinstein IB; Goodman DS
J Cell Physiol; 1986 May; 127(2):216-22. PubMed ID: 3634776
[TBL] [Abstract][Full Text] [Related]
19. Effects of 25-hydroxycholesterol, cholesterol, and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells.
Larsson O; Zetterberg A
J Cell Physiol; 1986 Oct; 129(1):94-102. PubMed ID: 3760035
[TBL] [Abstract][Full Text] [Related]
20. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
Buechler RD; Peffley DM
Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
